IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11000511 B1

PDFFull Text
Date of Patent:
May. 11, 2021

Filed:

Mar. 21, 2018

Chemical compounds as antibiotics

Applicant:

Antabio Sas, Labege, FR;

Inventors:

Simon Leiris, Labege, FR;

David Thomas Davies, Labege, FR;

Martin Everett, Labege, FR;

Nicolas Sprynski, Labege, FR;

Jonathan Mark Sutton, Margate Kent, GB;

Michael Steven Bodnarchuk, Margate Kent, GB;

Thomas David Pallin, Margate Kent, GB;

Andrew Peter Cridland, Margate Kent, GB;

Toby Jonathan Blench, Margate Kent, GB;

David Edward Clark, Margate Kent, GB;

Richard Leonard Elliott, Margate Kent, GB;

Lilha Beyria, Labege, FR;

Assignee:

Antabio SAS, Labege, FR;

Attorneys:

Panitch Schwarze Belisario & Nadel LLP

Lars H. Genieser

Primary Examiner:

Matthew P Coughlin

Int. Cl.
CPC ...
C07D 207/14 (2006.01); C07D 209/14 (2006.01); C07D 213/56 (2006.01); C07D 231/12 (2006.01); C07D 235/14 (2006.01); C07D 235/16 (2006.01); C07D 277/64 (2006.01); C07D 307/81 (2006.01); C07D 401/12 (2006.01); C07D 417/10 (2006.01); C07D 487/10 (2006.01); C07D 513/04 (2006.01); A61K 31/4184 (2006.01); A61K 31/195 (2006.01); A61K 31/343 (2006.01); A61K 31/357 (2006.01); A61K 31/381 (2006.01); A61K 31/402 (2006.01); A61K 31/404 (2006.01); A61K 31/415 (2006.01); A61K 31/423 (2006.01); A61K 31/426 (2006.01); A61K 31/437 (2006.01); A61K 31/472 (2006.01); A61K 31/496 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 31/195 (2013.01); A61K 31/343 (2013.01); A61K 31/357 (2013.01); A61K 31/381 (2013.01); A61K 31/402 (2013.01); A61K 31/404 (2013.01); A61K 31/415 (2013.01); A61K 31/423 (2013.01); A61K 31/426 (2013.01); A61K 31/437 (2013.01); A61K 31/472 (2013.01); A61K 31/496 (2013.01); A61K 45/06 (2013.01); C07D 207/14 (2013.01); C07D 209/14 (2013.01); C07D 213/56 (2013.01); C07D 231/12 (2013.01); C07D 235/14 (2013.01); C07D 235/16 (2013.01); C07D 277/64 (2013.01); C07D 307/81 (2013.01); C07D 401/12 (2013.01); C07D 417/10 (2013.01); C07D 487/10 (2013.01); C07D 513/04 (2013.01);
Abstract

The invention relates to a compound which is an indane derivative according to Formula (I), or a pharmaceutically acceptable salt thereof, [FORMULA (I)] wherein R, R, R, n, R, p, q, L, X and m are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics. The compounds can also be used in vitro, for example in cleaning compositions.

Find Patent Forward Citations

Loading…